The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Droncit Tablets 50 mg

50.0 mg/tablet Tablet

Vetoquinol SAVPA10521/005/001

Main Information

Trade NameDroncit Tablets 50 mg
Active SubstancesPraziquantel
Strength50.0 mg/tablet
Dosage FormTablet
Licence HolderVetoquinol SA
Licence NumberVPA10521/005/001

Group Information

ATC CodeQP52AA01 praziquantel
Therapeutic ClassEndoparasiticide


Licence Issued01/10/1989
Legal StatusCAM: Companion Animal Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back